Deltex Medical Group (DEMG.L) Stock Price
£0.043 14%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
3 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Deltex Medical Group, AI stock picks, stock alerts and much more.
DEMG.L AI Stock Analysis
AI stock analysis for DEMG.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Deltex Medical Group (DEMG.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Deltex Medical Group (DEMG.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Deltex Medical Group (DEMG.L), currently trading at £0.043, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About DEMG.L
-
Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally.
-
Symbol
DEMG.L
-
Market
LSE
-
Industry
Medical - Devices
-
Market Cap
805813
Similar Stocks
 |
Creo Medical Limited CREO.L |
£18.14 1.4% |
4 |
 |
MaxCyte MXCT.L |
£352 0.9% |
5 |
 |
Smith & Nephew SN.L |
£1029.5 1.1% |
5 |
 |
Novacyt S.A. NCYT.L |
£51.5 1% |
4 |
 |
Belluscura BELL.L |
£6.32 2.7% |
3 |
News
No news articles.
DEMG.L Alternative Data
Web Traffic
Deltex Medical Group receives an estimated 16298 monthly visitors to deltexmedical.com.
-
Web Traffic
16298
-
Change from Previous Month
5.8%
-
3 Month Change
11%
News Mentions
Deltex Medical Group was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Deltex Medical Group has 180 Twitter Followers on its main Twitter (also known as X) account.
-
Twitter Followers
180
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.1%
Youtube Subscribers
Deltex Medical Group has 76 subscribers on its main Youtube channel.
-
Youtube Subscribers
76
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
5.6%
LinkedIn Followers
2,229 are following Deltex Medical Group on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
2229
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.4%
Job Postings
Deltex Medical Group currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Deltex Medical Group has 38 employees.
-
LinkedIn Employees
38
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
2.6%
App Downloads
-
App Downloads
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
50%
Business Outlook
-
Business Outlook
58
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
DEMG.L Financials
DEMG.L Key Metrics
-
Total Revenue
£1.1M
-
Net Income
-£546K
-
Earnings per Share
-£0.0003
-
Free cash flow
-£446K
-
EBITDA
-£403K
-
EBITDA Ratio
-0.378759
-
Total Assets
£5.5M
DEMG.L 2-year Revenue & Income
DEMG.L 2-year Free Cash Flow
DEMG.L Technicals
DEMG.L SMA
DEMG.L RSI
FAQ
What's the current price of Deltex Medical Group (DEMG.L) Stock?
The price of an Deltex Medical Group (DEMG.L) share is £0.043.
What's the market cap of Deltex Medical Group?
The current market cap of Deltex Medical Group is 805813.
Should I buy or sell DEMG.L?
Deltex Medical Group exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Deltex Medical Group a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Deltex Medical Group stock. There are several bearish signals and market challenges that could negatively impact Deltex Medical Group's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Deltex Medical Group (DEMG.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Deltex Medical Group stock right now, as the outlook appears bearish.
What are some stocks similar to Deltex Medical Group (DEMG.L) that investors often compare it to?
Deltex Medical Group (DEMG.L) is often compared to similar stocks such as Creo Medical Limited, MaxCyte, Smith & Nephew, Novacyt S.A. and Belluscura.
What is the forecast for Deltex Medical Group's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Deltex Medical Group's stock price to be around £0.04 in 2026. Starting from the current price of £0.043, this represents a 7% change in price, indicating a bearish outlook for the stock.
How to buy Deltex Medical Group (DEMG.L) Stock?
Deltex Medical Group stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Deltex Medical Group shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.